Company Filing History:

30 out of 12,157

Bayer Aktiengesellschaft

patents

1 out of 579

Wayne State University

patents

1 out of 1

Baker Aktiengesellshaft

patent

Years Active: 1976-1988

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4760066 - Method for treating human tumor cell metastasis (1988-07-26),

2. 4444770 - New imidazoazole-alkenoic acid amide compounds, intermediate products (1984-04-24),

3. 4288446 - Pyrazol-5-ones (1981-09-08),

4. 4265898 - Imidazo[2,1-b]-[1,3,4]-thiadiazole compounds, composition and their (1981-05-05),

5. 4207325 - 4-Substituted pyrazoles (1980-06-10),

6. 4160098 - Pyrazole derivatives (1979-07-03),

7. 4122281 - 5-Sulphonyloxy pyrazole derivatives (1978-10-24),

8. 4122280 - Pyrazole derivatives (1978-10-24),

9. 4122279 - Pyrazole derivatives (1978-10-24),

10. 4117145 - 1-Substituted pyrazoles (1978-09-26),

11. 4117143 - 1-Substituted pyrazoles (1978-09-26),

12. 4113957 - 1-Substituted pyrazoles (1978-09-12),

13. 4113872 - 4-Substituted pyrazoles (1978-09-12),

14. 4112227 - Pyrazol-5-ones (1978-09-05),

15. 4112109 - 4-Substituted pyrazoles (1978-09-05),

Title: Eike Moller: Innovator in Cancer Treatment

Introduction

Eike Moller, a prolific inventor based in Wuppertal, Germany, holds an impressive portfolio of 32 patents. His contributions to the field of medical innovations, particularly in cancer treatment, have significantly advanced therapeutic methodologies.

Latest Patents

Among his latest patents, Moller has developed a method for treating human tumor cell metastasis. This therapeutic approach focuses on administering a therapeutically effective amount of 3-methyl-1-[2-(2-naphthyloxy)-ethyl]-2-pyrazolin-5-one or its pharmaceutically acceptable salt. Additionally, he has patented new imidazoazole-alkenoic acid amide compounds, describing their production methods and their applications in medical compositions. This invention also includes carbonyl compounds and alkenoic acids as intermediates, further showcasing his innovative approach to cancer therapies.

Career Highlights

Eike Moller has made significant strides in his career, having worked with renowned organizations such as Bayer Aktiengesellschaft and Wayne State University. His work in these institutions has been instrumental in the advancement of research in pharmaceuticals, particularly in oncology.

Collaborations

Throughout his career, Moller has collaborated with notable professionals in his field, including Harald Horstmann and Egbert Wehinger. His partnerships with such expertise have fostered fruitful innovation and development of groundbreaking therapies.

Conclusion

Eike Moller’s dedication to medical innovation is evident through his extensive patent portfolio and collaborations with distinguished institutions and professionals. His work continues to influence the landscape of cancer treatment, illustrating the impact of innovative thinking and collaboration in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.